Tracers / [18F]JMV5763

[18F]JMV5763

Also written as [18F]JMV5763; [F-18]JMV5763
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
Stage
Syntheses indexed
1

What it is

Compound class
NODA-MPAA functionalized JMV5763, a short analog of TLQP-21 neuropeptide
Target / mechanism
Clinical application
Theranostic pair

Regulatory status

FDA
EMA (centralised)
Other approvals
Brand names

Clinical use

Typical injected activity
Uptake time

Reported in the literature. Not a dosing recommendation.

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
TRACERlab FX N Pro
GE HealthCare
custom manifoldSPE33.8 ± 2%
no
99.0 ± 5%NODA-MPAA functionalized JMV5763
CheMatech (Dijon, France) [chelator]; synthesized in-house [peptide]
30542281
2018 Front Pharmacol
fully automated using a GE TRACERlab FX-N Pro synthesis module — Radiochemical yield, not corrected for decay, was of 33.8 ± 2%.

Need this precursor?We can point you to suppliers for [18F]JMV5763, or handle the enquiry for you.

Get in touch

Quality control Preliminary — inferred from compound class

Ph. Eur. monograph
USP monograph
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F]JMV5763.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18. Compound class inferred from precursor name (not stated outright) -- PMID 30542281: 'NODA-MPAA functionalized JMV5763'.